These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


339 related items for PubMed ID: 17704357

  • 1. Gadolinium-enhanced MR imaging and nephrogenic systemic fibrosis: retrospective study of a renal replacement therapy cohort.
    Collidge TA, Thomson PC, Mark PB, Traynor JP, Jardine AG, Morris ST, Simpson K, Roditi GH.
    Radiology; 2007 Oct; 245(1):168-75. PubMed ID: 17704357
    [Abstract] [Full Text] [Related]

  • 2. Nephrogenic systemic fibrosis: a report of 29 cases.
    Shabana WM, Cohan RH, Ellis JH, Hussain HK, Francis IR, Su LD, Mukherji SK, Swartz RD.
    AJR Am J Roentgenol; 2008 Mar; 190(3):736-41. PubMed ID: 18287446
    [Abstract] [Full Text] [Related]

  • 3. Gadolinium-based contrast exposure, nephrogenic systemic fibrosis, and gadolinium detection in tissue.
    Wiginton CD, Kelly B, Oto A, Jesse M, Aristimuno P, Ernst R, Chaljub G.
    AJR Am J Roentgenol; 2008 Apr; 190(4):1060-8. PubMed ID: 18356456
    [Abstract] [Full Text] [Related]

  • 4. Nephrogenic systemic fibrosis: risk factors and incidence estimation.
    Sadowski EA, Bennett LK, Chan MR, Wentland AL, Garrett AL, Garrett RW, Djamali A.
    Radiology; 2007 Apr; 243(1):148-57. PubMed ID: 17267695
    [Abstract] [Full Text] [Related]

  • 5. Risk of nephrogenic systemic fibrosis: evaluation of gadolinium chelate contrast agents at four American universities.
    Wertman R, Altun E, Martin DR, Mitchell DG, Leyendecker JR, O'Malley RB, Parsons DJ, Fuller ER, Semelka RC.
    Radiology; 2008 Sep; 248(3):799-806. PubMed ID: 18632533
    [Abstract] [Full Text] [Related]

  • 6. Nephrogenic systemic fibrosis after exposure to gadolinium in patients with renal failure.
    Othersen JB, Maize JC, Woolson RF, Budisavljevic MN.
    Nephrol Dial Transplant; 2007 Nov; 22(11):3179-85. PubMed ID: 17890246
    [Abstract] [Full Text] [Related]

  • 7. Nephrogenic systemic fibrosis: possible association with a predisposing infection.
    Golding LP, Provenzale JM.
    AJR Am J Roentgenol; 2008 Apr; 190(4):1069-75. PubMed ID: 18356457
    [Abstract] [Full Text] [Related]

  • 8. Gadolinium-associated nephrogenic systemic fibrosis.
    Schlaudecker JD, Bernheisel CR.
    Am Fam Physician; 2009 Oct 01; 80(7):711-4. PubMed ID: 19817341
    [Abstract] [Full Text] [Related]

  • 9. Gadolinium-containing magnetic resonance imaging contrast and nephrogenic systemic fibrosis: a case-control study.
    Kallen AJ, Jhung MA, Cheng S, Hess T, Turabelidze G, Abramova L, Arduino M, Guarner J, Pollack B, Saab G, Patel PR.
    Am J Kidney Dis; 2008 Jun 01; 51(6):966-75. PubMed ID: 18501784
    [Abstract] [Full Text] [Related]

  • 10. Gadolinium and nephrogenic systemic fibrosis: association or causation.
    Kurtkoti J, Snow T, Hiremagalur B.
    Nephrology (Carlton); 2008 Jun 01; 13(3):235-41. PubMed ID: 18221255
    [Abstract] [Full Text] [Related]

  • 11. Recent topics related to nephrogenic systemic fibrosis associated with gadolinium-based contrast agents.
    Kitajima K, Maeda T, Watanabe S, Ueno Y, Sugimura K.
    Int J Urol; 2012 Sep 01; 19(9):806-11. PubMed ID: 22571387
    [Abstract] [Full Text] [Related]

  • 12. Nephrogenic systemic fibrosis: is gadolinium the missing piece to the puzzle?
    Bennett LK, Garrett AL.
    Cutis; 2008 May 01; 81(5):421-6. PubMed ID: 18543594
    [Abstract] [Full Text] [Related]

  • 13. Nephrogenic systemic fibrosis: center case review.
    Lauenstein TC, Salman K, Morreira R, Tata S, Tudorascu D, Baramidze G, Singh-Parker S, Martin DR.
    J Magn Reson Imaging; 2007 Nov 01; 26(5):1198-203. PubMed ID: 17969162
    [Abstract] [Full Text] [Related]

  • 14. Association of gadolinium based magnetic resonance imaging contrast agents and nephrogenic systemic fibrosis.
    Bhave G, Lewis JB, Chang SS.
    J Urol; 2008 Sep 01; 180(3):830-5; discussion 835. PubMed ID: 18635232
    [Abstract] [Full Text] [Related]

  • 15. An epidemic outbreak of nephrogenic systemic fibrosis in a Danish hospital.
    Marckmann P.
    Eur J Radiol; 2008 May 01; 66(2):187-90. PubMed ID: 18328659
    [Abstract] [Full Text] [Related]

  • 16. [Nephrogenic systemic fibrosis].
    Breitschaft A, Stahlmann R.
    Med Monatsschr Pharm; 2009 Oct 01; 32(10):377-82. PubMed ID: 19886227
    [Abstract] [Full Text] [Related]

  • 17. Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines.
    Wang Y, Alkasab TK, Narin O, Nazarian RM, Kaewlai R, Kay J, Abujudeh HH.
    Radiology; 2011 Jul 01; 260(1):105-11. PubMed ID: 21586680
    [Abstract] [Full Text] [Related]

  • 18. Update on nephrogenic systemic fibrosis.
    Thomsen HS, Marckmann P, Logager VB.
    Magn Reson Imaging Clin N Am; 2008 Nov 01; 16(4):551-60, vii. PubMed ID: 18926421
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.